-
Clare Martin
Director of Operations
Clare is a Certified Clinical Research Professional based in Columbus, Ohio. She received her Masters of Pharmacology and Masters in Applied Clinical and Preclinical Research from THE Ohio State University in Columbus, Ohio. She has 10 years of experience in hematology clinical research from both the patient-facing coordinator and project management sides. Clare is a Certified Revenue Cycle Representative through HFMA.
-
Gabrielle Dean
Project Manager
Gabrielle Dean is a Certified Clinical Research Professional and Project Manager based in Atlanta, Georgia. She received her Masters of Public Health in Health Promotion & Behavior from the University of Georgia in Athens, GA. She has several years of experience in both pediatric and adult hematology clinical research from both the patient-facing coordinator and project management sides. Her areas of particular interest are rare blood cell disorders and thrombotic microangiopathy.
-
Brent Oliver
Graphic Designer
Brent Oliver is an accomplished graphic designer with experience ranging from measurable corporate contributions to highly rated freelance work to a widely viewed, personally produced social media channel. He now works alongside both Hitec Group USA and the United States Thrombotic Microangiopathy Alliance & Consortium (USTMA) to ensure all content is easily accessible, legible and unique. He works across all mediums to provide universal brand consistency, no matter the format.
-
Beth McGraw
Patient Advisory Board Lead
Personal Connection: My journey with patient advocacy began when I was diagnosed with iTTP on February 16, 2022, at the age of 38. This experience, coupled with the inspiration from my mother, who battled lung disease and became a resource for other patients, fueled my desire to support others facing similar challenges. My mother’s resilience and dedication to helping others, even while she awaited and received a lung transplant, left a lasting impact on me.
Patient Advocacy: Motivated by my mother’s legacy and my own diagnosis, I met with Clare Martin at USTMA to discuss an idea, and the patient ambassador program was born. This initiative connects new patients with TTP survivors who can offer support and resources, fostering a sense of community and belonging. My goal is to continue leading such initiatives, ensuring that patients have a voice and access to the support they need.